Skip to content

Clinical trials

Chronic Limb-Threatening Ischemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Limb-Threatening Ischemia Country / region: China Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20103
20112
20121
20181
20193
20202
20212
20221
20232
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11
Completed7
Not yet recruiting2
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Northland Biotech. Co., Ltd.4
Peking Union Medical College Hospital3
Xuanwu Hospital, Beijing3
Fudan University2
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology2
Allife Medical Science and Technology Co., Ltd.1
Beijing Tsinghua Chang Gung Hospital1
Biotyx Medical (Shenzhen) Co., Ltd.1
First Affiliated Hospital of Wenzhou Medical University1
First Affiliated Hospital, Sun Yat-Sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Limb-Threatening Ischemia23
Arterial Occlusive Diseases5
Peripheral Arterial Disease5
Peripheral Vascular Diseases4
Ulcer4
Diabetic Foot3
Ischemia3
Vascular Diseases3
Diabetes Mellitus2
Thromboangiitis Obliterans2

Trials

Showing 26 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.